STOCK TITAN

KCK Ltd. reports 1.44M shares in Sight Sciences (SGHT) — 2.7% stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Sight Sciences, Inc. Schedule 13G/A amendment shows KCK Ltd. and Nael Karim Kassar beneficially own 1,438,094 shares of Common Stock, representing 2.7% of the class based on 54,005,984 shares outstanding as of February 26, 2026. The filing reports shared voting and dispositive power over these shares and is signed by the filer and Sight Sciences' CEO.

Positive

  • None.

Negative

  • None.

Insights

Passive holder reports a sub-5% stake with shared control.

The filing lists 1,438,094 shares held by KCK Ltd./Nael Karim Kassar, equal to 2.7% of the outstanding common stock as of February 26, 2026. This position falls below the 5% reporting threshold that typically indicates passive investment intent under Schedule 13G/A.

Because the filing records shared voting and dispositive power, subsequent changes in voting arrangements or holdings would be the primary items to watch in future amendments.

Shared control implies coordinated ownership, not activist intent.

The cover data shows zero sole voting/dispositive power and 1,438,094 in shared power, which signals a non‑controlling stake. Schedule 13G/A classification generally reflects a passive investor rather than an intent to influence management.

Future filings may disclose whether the holder moves above reporting thresholds or shifts to a Schedule 13D, which would change governance implications.

Shares beneficially owned 1,438,094 shares Beneficial ownership reported by KCK Ltd./Nael Karim Kassar
Percent of class 2.7% Based on 54,005,984 shares outstanding as of February 26, 2026
Shares outstanding 54,005,984 shares Outstanding common stock as of February 26, 2026 (Form 10-K reference)
Shared voting power 1,438,094 shares Reported shared voting power on the cover page
Shared dispositive power 1,438,094 shares Reported shared dispositive power on the cover page
Schedule 13G/A regulatory
"Amendment No. 4; SCHEDULE 13G/A appears as the form type"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially owned financial
"Amount beneficially owned: 1,438,094 shares of Common Stock"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared dispositive power regulatory
"Shared Dispositive Power 1,438,094.00 listed on the cover page"





82657M105

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



KCK LTD.
Signature:/s/ Raphael Metz
Name/Title:Secretary
Date:04/08/2026
Nael Karim Kassar
Signature:/s/ Nael Karim Kassar
Name/Title:Founder and Chief Executive Officer
Date:04/08/2026

FAQ

What stake does KCK Ltd. hold in Sight Sciences (SGHT)?

KCK Ltd. beneficially owns 1,438,094 shares (2.7%). This percentage uses 54,005,984 shares outstanding as of February 26, 2026 reported in the issuer's Form 10-K.

Does the Schedule 13G/A filing indicate voting control by KCK Ltd.?

The filing reports shared voting and dispositive power, not sole control. It shows zero sole voting/dispositive power and shared power of 1,438,094 shares, per the cover page entries.

Is this a passive or active disclosure for SGHT?

This Schedule 13G/A amendment reflects a passive investor disclosure. Holdings are below 5% and the filing is an amendment to a 13G, typically used by passive holders.

What outstanding share count was used to calculate the 2.7%?

The percentage is based on 54,005,984 shares outstanding as of February 26, 2026. That figure comes from Sight Sciences' Annual Report on Form 10-K filed March 4, 2026.

Who signed the Schedule 13G/A amendment for SGHT?

The amendment is signed by Raphael Metz (Secretary) and Nael Karim Kassar (Founder and CEO). Signatures are dated April 8, 2026 on the filing excerpt.